Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

Clinical trial NCT01575834 · COMPLETED

Trial details

NCT number: NCT01575834
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2012-03-15
Primary completion: 2015-12-14
Enrollment: 7180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.